Trial Profile
Effects of Exenatide on Motor Function and the Brain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Sep 2022
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 14 Sep 2022 Status changed from active, no longer recruiting to completed.
- 07 Jun 2021 Planned End Date changed from 1 May 2021 to 1 May 2022.
- 16 Nov 2020 Planned primary completion date changed from 1 Oct 2020 to 1 Dec 2020.